VISTAGEN THERAPEUTICS INC - COM NEW (VTGN)

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class
Equity / COM NEW
Total 13F shares
1,778,904
Share change
+1,778,904
Total reported value
$6,939,000
Price per share
$3.90
Number of holders
10
Value change
+$6,939,000
Number of buys
10

Institutional Holders of VISTAGEN THERAPEUTICS INC - COM NEW (VTGN) as of Q2 2016

As of 30 Jun 2016, VISTAGEN THERAPEUTICS INC - COM NEW (VTGN) was held by 10 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,778,904 shares. The largest 10 holders included SABBY MANAGEMENT, LLC, New Leaf Venture Partners, L.L.C., Parallax Volatility Advisers, L.P., SPHERA FUNDS MANAGEMENT LTD., NEXTHERA CAPITAL LP, DAFNA Capital Management LLC, HighTower Advisors, LLC, LADENBURG THALMANN FINANCIAL SERVICES INC, Hartford Financial Management Inc., and BANK OF AMERICA CORP /DE/. This page lists 10 institutional shareholders reporting positions in this security for the Q2 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.